eDiagnosis released its performance for the first three quarters, with a net profit attributable to the parent company of 13.5155 million yuan, a decrease of 83.30%

According to the Zhitong Finance APP, eDiagnosis released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 227 million yuan, a year-on-year increase of 0.53%. The net profit attributable to shareholders of the listed company was 13.5155 million yuan, a year-on-year decrease of 83.30%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 63.3294 million yuan. The basic earnings per share were 0.0616 yuan